HK1068154A1 - Anaplastic lymphoma kinase assay, reagent and compositions thereof - Google Patents

Anaplastic lymphoma kinase assay, reagent and compositions thereof

Info

Publication number
HK1068154A1
HK1068154A1 HK05101314A HK05101314A HK1068154A1 HK 1068154 A1 HK1068154 A1 HK 1068154A1 HK 05101314 A HK05101314 A HK 05101314A HK 05101314 A HK05101314 A HK 05101314A HK 1068154 A1 HK1068154 A1 HK 1068154A1
Authority
HK
Hong Kong
Prior art keywords
compositions
reagent
kinase assay
anaplastic lymphoma
lymphoma kinase
Prior art date
Application number
HK05101314A
Other languages
English (en)
Inventor
Lorenzo A Pinna
Arianna Donella-Deana
Oriano Marin
Luca Mologni
Rosalind Gunby
Carlo Gambacorti Passerini
Leonardo Scapozza
Original Assignee
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Naz Stud Cura Dei Tumori filed Critical Ist Naz Stud Cura Dei Tumori
Publication of HK1068154A1 publication Critical patent/HK1068154A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK05101314A 2003-03-07 2005-02-17 Anaplastic lymphoma kinase assay, reagent and compositions thereof HK1068154A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03005186A EP1454992B1 (de) 2003-03-07 2003-03-07 Anaplastisches Lymphoma Kinase Testverfahren, Reagenzien und Kompositionen davon

Publications (1)

Publication Number Publication Date
HK1068154A1 true HK1068154A1 (en) 2005-04-22

Family

ID=32798804

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05101314A HK1068154A1 (en) 2003-03-07 2005-02-17 Anaplastic lymphoma kinase assay, reagent and compositions thereof

Country Status (15)

Country Link
US (1) US20070031907A1 (de)
EP (1) EP1454992B1 (de)
JP (1) JP2006519800A (de)
CN (1) CN100345978C (de)
AT (1) ATE328112T1 (de)
CA (1) CA2518094A1 (de)
CY (1) CY1106115T1 (de)
DE (1) DE60305634T2 (de)
DK (1) DK1454992T3 (de)
ES (1) ES2263862T3 (de)
HK (1) HK1068154A1 (de)
IL (1) IL170669A0 (de)
PT (1) PT1454992E (de)
SI (1) SI1454992T1 (de)
WO (1) WO2004079326A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2561406T3 (es) 2006-04-14 2016-02-26 Cell Signaling Technology, Inc. Defectos de genes y quinasa ALK mutante en tumores sólidos humanos
US8168383B2 (en) 2006-04-14 2012-05-01 Cell Signaling Technology, Inc. Gene defects and mutant ALK kinase in human solid tumors
EP2107054A1 (de) 2008-04-01 2009-10-07 Università Degli Studi Di Milano - Bicocca Antiproliferative Verbindungen und therapeutische Verwendungen dafür
EP2274288A2 (de) 2008-04-24 2011-01-19 Incyte Corporation Makrocyclische verbindungen und ihre verwendung als kinaseinhibitoren
EP2161271A1 (de) 2008-09-08 2010-03-10 Università Degli Studi Di Milano - Bicocca Alpha-Carbolin-Hemmer von NMP-ALK, RET und Bcr-Abl
WO2010085597A1 (en) 2009-01-23 2010-07-29 Incyte Corporation Macrocyclic compounds and their use as kinase inhibitors
US9126931B2 (en) * 2009-06-10 2015-09-08 Chugai Seiyaku Kabushiki Kaisha Tetracyclic compound
CN101955995B (zh) * 2010-06-17 2013-06-26 江苏迈迪基因生物科技有限公司 淋巴瘤相关的融合基因的诊断试剂盒
US20120101108A1 (en) 2010-08-06 2012-04-26 Cell Signaling Technology, Inc. Anaplastic Lymphoma Kinase In Kidney Cancer
WO2012023597A1 (ja) 2010-08-20 2012-02-23 中外製薬株式会社 ４環性化合物を含む組成物
EP2847353B1 (de) 2012-05-10 2022-01-19 The General Hospital Corporation Verfahren zur bestimmung einer nukleotidsequenz
TR201815994T4 (tr) 2012-09-25 2018-11-21 Chugai Pharmaceutical Co Ltd Ret inhibitörü.
WO2014128235A1 (en) 2013-02-22 2014-08-28 F. Hoffmann-La Roche Ag Methods of treating cancer and preventing drug resistance
US10450597B2 (en) 2014-01-27 2019-10-22 The General Hospital Corporation Methods of preparing nucleic acids for sequencing
CA2946268A1 (en) 2014-04-25 2015-10-29 Chugai Seiyaku Kabushiki Kaisha Crystal of tetracyclic compound
KR102412321B1 (ko) 2014-04-25 2022-06-22 추가이 세이야쿠 가부시키가이샤 4환성 화합물을 고용량 함유하는 제제
TWI718102B (zh) 2014-08-08 2021-02-11 日商中外製藥股份有限公司 ４環性化合物的非晶質體
RU2740261C2 (ru) 2015-01-16 2021-01-12 Чугаи Сейяку Кабусики Кайся Комбинированное лекарственное средство
CN109937254B (zh) 2016-09-15 2023-05-30 阿谢尔德克斯有限责任公司 核酸样品制备方法
CA3037190A1 (en) 2016-09-15 2018-03-22 ArcherDX, Inc. Methods of nucleic acid sample preparation for analysis of cell-free dna
EP4198140A1 (de) 2016-11-02 2023-06-21 ArcherDX, LLC Verfahren zur nukleinsäureprobenvorbereitung für immunrepertoiresequenzierung
WO2020050241A1 (ja) 2018-09-04 2020-03-12 中外製薬株式会社 ４環性化合物の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05126833A (ja) * 1991-10-31 1993-05-21 Tosoh Corp チロシンキナ−ゼ活性の免疫化学的測定法及びそのキツト
AU4281393A (en) * 1992-04-10 1993-11-18 Dana-Farber Cancer Institute, Inc. Activation-state-specific phosphoprotein immunodetection
ES2136103T3 (es) * 1992-06-22 1999-11-16 Kyowa Hakko Kogyo Kk Procedimiento para la preparacion de derivados de estaurosporina.
GB9314271D0 (en) * 1993-07-09 1993-08-18 Inst Of Cancer The Research Cell growth factor receptors
US6001621A (en) * 1993-11-23 1999-12-14 Genetech, Inc. Protein tyrosine kinases
CA2175892C (en) * 1993-11-23 2000-03-07 Paul J. Godowski Kinase receptor activation assay
US5529925A (en) * 1993-12-03 1996-06-25 St. Jude Children's Research Hospital Nucleic acid sequences and fusion proteins present in human t(2;5) lymphoma
US5763198A (en) * 1994-07-22 1998-06-09 Sugen, Inc. Screening assays for compounds
US5759787A (en) * 1996-08-26 1998-06-02 Tularik Inc. Kinase assay
CA2288221A1 (en) * 1997-04-28 1998-11-05 Sugen, Inc. Diagnosis and treatment of phosphatase 0r kinase-related disorders
US6806266B1 (en) * 1999-07-13 2004-10-19 Kyowa Hakko Kogyo Co., Ltd. Staurosporin derivatives

Also Published As

Publication number Publication date
JP2006519800A (ja) 2006-08-31
CN1756850A (zh) 2006-04-05
CY1106115T1 (el) 2011-06-08
ATE328112T1 (de) 2006-06-15
WO2004079326A2 (en) 2004-09-16
US20070031907A1 (en) 2007-02-08
DE60305634T2 (de) 2006-09-21
WO2004079326A3 (en) 2004-12-09
EP1454992B1 (de) 2006-05-31
IL170669A0 (en) 2011-08-01
SI1454992T1 (sl) 2006-10-31
EP1454992A1 (de) 2004-09-08
DK1454992T3 (da) 2006-10-02
ES2263862T3 (es) 2006-12-16
CN100345978C (zh) 2007-10-31
PT1454992E (pt) 2006-09-29
DE60305634D1 (de) 2006-07-06
CA2518094A1 (en) 2004-09-16

Similar Documents

Publication Publication Date Title
HK1068154A1 (en) Anaplastic lymphoma kinase assay, reagent and compositions thereof
WO2005111212A3 (en) Biological bar code
AU2003278725A1 (en) Polynucleotide predictor set for identifying protein tyrosine kinase modulators
ATE386815T1 (de) Methoden und syteme zur überwachung intrazellulärer bindereaktionen
WO2004020458A3 (en) Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents
WO2002047535A3 (en) High throughput assay to detect inhibitors of the map kinase pathway
HK1080074A1 (zh) 作為酪氨酸蛋白激酶抑制劑的4，6-二氨基取代-2-[氧基或氨氧基]-[1，3，5]三嗪
EP1395275A4 (de) Beta-secretase-substrate und ihre verwendung
WO2004050842A3 (en) Atm kinase compositions and methods
WO2002053743A3 (en) Mammalian tribbles signaling pathways and methods and reagents related thereto
EP2253722A3 (de) Reagenzien und Verfahren zur Erfassung vom schweren akuten Atemwegssyndromassoziierten (SARS) coronavirus
AU2002243912A1 (en) Biosensor for detecting chemical agents
DE602006021548D1 (de) Probenlyse und beschichtung einer reaktionsoberfläche
WO2003008635A8 (en) η-SECRETASE IN VITRO SCREENING ASSAY
DK1224222T3 (da) Chemokinreceptor
WO2004084708A3 (en) Finding usable portion of sigmoid curve
WO2005100386A3 (en) Canine cold-and menthol-sensitive receptor 1
WO2005003388A3 (en) Fluorescence assays for nucleic acid polymerase activity
HK1116517A1 (en) Enzymatic measurement of imatinib mesylate
DE60226244D1 (de) Il-4 rezeptor sequenzvarianten, die mit typ i diabetes assoziiert sind
WO2004020980A3 (en) Assays for the detection of biliverdin in birds and reptiles
WO2001071342A3 (en) Identification of mast cell/basophil activation inhibitors
WO2005026378A3 (en) Methods for gene function analysis
AU2003293303A1 (en) Screening assay for identifying agents that modulate pak kinase or cd45 tyrosine phosphatase activity
NO20013748L (no) Ny analyse

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100307